+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bird Flu Treatment Market - Global Forecast 2025-2030- Product Image
Bird Flu Treatment Market - Global Forecast 2025-2030- Product Image
Sale

Bird Flu Treatment Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010916
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The bird flu treatment market is evolving rapidly, driven by scientific innovation, regulatory changes, and shifting global health priorities. Senior decision-makers require a clear understanding of market drivers, segment dynamics, and strategy to address the growing challenges and opportunities in this field.

Market Snapshot: Bird Flu Treatment Market Growth Trajectory

The Bird Flu Treatment Market grew from USD 23.85 billion in 2024 to USD 25.86 billion in 2025. It is expected to continue growing at a CAGR of 8.21%, reaching USD 38.30 billion by 2030. Robust expansion is underpinned by ongoing outbreaks, rapid therapeutic advances, and increasing demand for faster diagnostics and innovative vaccines across multiple regions.

Scope & Segmentation

This report provides comprehensive coverage of the bird flu treatment landscape, mapping products, technologies, applications, administration routes, and end users. Strategic segmentation and regional analysis are designed to help senior leaders identify emerging market opportunities and manage evolving operational risks. Key segmentation areas include:

  • Product Types: Antiviral drugs (adamantanes, neuraminidase inhibitors, polymerase inhibitors, combination therapies), diagnostic kits (molecular, serological, point of care, rapid tests), supportive care (oxygen therapy, rehydration, symptom management, telehealth monitoring), vaccines (inactivated, live attenuated, mRNA, recombinant).
  • Administration Routes: Inhalation (dry powder, metered dose inhalers, nebulizers), injectables (intramuscular, subcutaneous, nanoparticle delivery), intravenous (central and peripheral line, smart infusion pumps), oral (capsules, tablets, suspensions, sublingual).
  • End Users: Clinics (community health, outpatient, specialty), hospitals (private, public, specialized care centers), laboratories (hospital labs, independent labs, point of care testing), pharmacies (retail, mail order, online).
  • Applications: Human health (adult, pediatric, geriatric), animal health (livestock, poultry, wild birds), recognizing zoonotic risk factors.
  • Key Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), EMEA (United Kingdom, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Leading Companies: Major contributors include F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Sanofi S.A., Novartis AG, CSL Limited, Pfizer Inc., Fujifilm Toyama Chemical Co., Ltd., Seqirus Pty Ltd, Shionogi & Co., Ltd., and BioCryst Pharmaceuticals, Inc.

Key Takeaways for Strategic Decision-Makers

  • Rapid scientific progress is reshaping the competitive landscape, requiring continuous portfolio realignment and investment in R&D for antiviral and vaccine development.
  • Technological integration, notably in molecular diagnostics and telehealth, supports both early detection and remote patient management, optimizing resource utilization during outbreaks.
  • Collaborative models between pharmaceutical companies, biotech firms, and digital health providers enable more effective supply chain management and product delivery, responding promptly to surges in demand.
  • Regulatory agility, including adaptive licensing processes and accelerated reviews, is facilitating faster market entry for high-priority therapies and diagnostics.
  • Growth in mRNA and recombinant vaccine platforms signals a shift towards scalable, rapid-response solutions, with potential to address emerging viral strains efficiently.
  • Regional infrastructure and local manufacturing efforts are becoming critical differentiators in improving access and resilience, especially for underserved populations.

Tariff Impact on Supply Chain and Cost Structure

New tariff measures implemented in 2025 have introduced notable pressures across the value chain, particularly within the United States. Elevated import duties on active pharmaceutical ingredients and critical diagnostic components are prompting organizations to reassess supply chain strategies, including increased domestic sourcing and inventory adjustments. These shifts may impact outbreak response times and the overall affordability of treatments, compelling manufacturers and healthcare systems to weigh the merits of local production against persistent reliance on global suppliers.

Methodology & Data Sources

The research leverages primary interviews with virology experts, clinicians, and public health analysts, complemented by a rigorous secondary review of peer-reviewed publications, regulatory and patent databases. Triangulation of qualitative and quantitative insights ensures thorough validation of trends, segment dynamics, and benchmarking approaches, supporting data-driven recommendations for senior decision-makers.

Why This Report Matters

  • Enables alignment of product development and go-to-market strategies with evolving market demands, regulatory shifts, and technological innovation.
  • Provides in-depth segmentation and regional analysis to guide investment, supply chain, and partnership decisions across diverse geographies.
  • Delivers actionable insights for optimizing stakeholder engagement and operational resilience in the face of complex and shifting market dynamics.

Conclusion

This report equips decision-makers with the intelligence and clarity required to anticipate risks, leverage innovation, and shape successful strategies in the evolving bird flu treatment market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of monoclonal antibody therapies to target H5N1 viral proteins in avian influenza patients
5.2. Growing investment in rapid diagnostic platforms for early detection of avian influenza strains in poultry and humans
5.3. Expansion of antiviral drug research focusing on novel neuraminidase inhibitors with improved resistance profiles
5.4. Rising demand for prophylactic vaccines using mRNA technology to combat evolving bird flu virus subtypes
5.5. Implementation of One Health surveillance programs to integrate human and animal avian influenza monitoring
5.6. Strategic partnerships between biotech firms and agricultural producers to accelerate bird flu treatment development
5.7. Adoption of artificial intelligence and machine learning for predictive modeling of avian influenza outbreak risks
5.8. Regulatory incentives and expedited approval pathways driving innovation in bird flu therapeutic pipelines
5.9. Increasing focus on broad-spectrum antiviral agents capable of addressing multiple influenza A subtypes
5.10. Development of lipid nanoparticle-based drug delivery systems to enhance efficacy of baloxavir marboxil against avian influenza
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bird Flu Treatment Market, by Product Type
8.1. Introduction
8.2. Antiviral Drug
8.2.1. Adamantanes
8.2.2. Combination Therapy
8.2.3. Neuraminidase Inhibitors
8.2.4. Polymerase Inhibitors
8.3. Diagnostic Kit
8.3.1. Molecular Diagnostics
8.3.2. Point Of Care Molecular
8.3.3. Rapid Test Kits
8.3.4. Serological Diagnostics
8.4. Supportive Care
8.4.1. Oxygen Therapy
8.4.2. Rehydration Therapy
8.4.3. Symptom Management
8.4.4. Telehealth Monitoring
8.5. Vaccine
8.5.1. Inactivated Vaccine
8.5.2. Live Attenuated Vaccine
8.5.3. Mrna Vaccine
8.5.4. Recombinant Vaccine
9. Bird Flu Treatment Market, by Administration Route
9.1. Introduction
9.2. Inhalation
9.2.1. Dry Powder Inhaler
9.2.2. Metered Dose Inhaler
9.2.3. Nebulizer
9.3. Injectable
9.3.1. Intramuscular
9.3.2. Nanoparticle Delivery
9.3.3. Subcutaneous
9.4. Intravenous
9.4.1. Central Line
9.4.2. Peripheral Line
9.4.3. Smart Infusion Pumps
9.5. Oral
9.5.1. Capsule
9.5.2. Sublingual
9.5.3. Suspension
9.5.4. Tablet
10. Bird Flu Treatment Market, by End User
10.1. Introduction
10.2. Clinics
10.2.1. Community Health Centers
10.2.2. Outpatient Clinics
10.2.3. Specialty Clinics
10.3. Hospitals
10.3.1. Private Hospitals
10.3.2. Public Hospitals
10.3.3. Specialized Care Centers
10.4. Laboratories
10.4.1. Hospital Labs
10.4.2. Independent Labs
10.4.3. Point Of Care Testing
10.5. Pharmacies
10.5.1. Mail Order Pharmacies
10.5.2. Online Pharmacies
10.5.3. Retail Pharmacies
11. Bird Flu Treatment Market, by Application
11.1. Introduction
11.2. Animal Health
11.2.1. Livestock
11.2.2. Poultry
11.2.3. Wild Birds
11.3. Human Health
11.3.1. Adult Patients
11.3.2. Geriatric Patients
11.3.3. Pediatric Patients
12. Americas Bird Flu Treatment Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Bird Flu Treatment Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Bird Flu Treatment Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. F. Hoffmann-La Roche Ltd.
15.3.2. GlaxoSmithKline plc
15.3.3. Sanofi S.A.
15.3.4. Novartis AG
15.3.5. CSL Limited
15.3.6. Pfizer Inc.
15.3.7. Fujifilm Toyama Chemical Co., Ltd.
15.3.8. Seqirus Pty Ltd
15.3.9. Shionogi & Co., Ltd.
15.3.10. BioCryst Pharmaceuticals, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BIRD FLU TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BIRD FLU TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. BIRD FLU TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. BIRD FLU TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. BIRD FLU TREATMENT MARKET: RESEARCHAI
FIGURE 24. BIRD FLU TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 25. BIRD FLU TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 26. BIRD FLU TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BIRD FLU TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIRD FLU TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BIRD FLU TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ADAMANTANES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ADAMANTANES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY NEURAMINIDASE INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY NEURAMINIDASE INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY POLYMERASE INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY POLYMERASE INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY POINT OF CARE MOLECULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY POINT OF CARE MOLECULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY RAPID TEST KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY RAPID TEST KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SEROLOGICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SEROLOGICAL DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY OXYGEN THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY OXYGEN THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY REHYDRATION THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY REHYDRATION THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SYMPTOM MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SYMPTOM MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY TELEHEALTH MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY TELEHEALTH MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY MRNA VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY MRNA VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY RECOMBINANT VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY RECOMBINANT VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY NEBULIZER, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY NANOPARTICLE DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY NANOPARTICLE DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY CENTRAL LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY CENTRAL LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PERIPHERAL LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PERIPHERAL LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SMART INFUSION PUMPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SMART INFUSION PUMPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SUBLINGUAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SUBLINGUAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SUSPENSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY COMMUNITY HEALTH CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY COMMUNITY HEALTH CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SPECIALIZED CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SPECIALIZED CARE CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY HOSPITAL LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY HOSPITAL LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY MAIL ORDER PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY MAIL ORDER PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, BY REGION, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, BY REGION, 2025-2030 (USD MILLION)
TABLE 149. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY LIVESTOCK, BY REGION, 2025-2030 (USD MILLION)
TABLE 151. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY POULTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY POULTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 153. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY WILD BIRDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 154. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY WILD BIRDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 155. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2024 (USD MILLION)
TABLE 156. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2025-2030 (USD MILLION)
TABLE 157. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, BY REGION, 2018-2024 (USD MILLION)
TABLE 158. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, BY REGION, 2025-2030 (USD MILLION)
TABLE 159. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ADULT PATIENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 160. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ADULT PATIENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 161. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY GERIATRIC PATIENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 162. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY GERIATRIC PATIENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 163. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PEDIATRIC PATIENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 164. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PEDIATRIC PATIENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 165. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2024 (USD MILLION)
TABLE 166. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 185. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 186. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 187. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 190. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 191. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 192. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 193. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2024 (USD MILLION)
TABLE 194. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2025-2030 (USD MILLION)
TABLE 195. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2024 (USD MILLION)
TABLE 196. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2025-2030 (USD MILLION)
TABLE 197. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2024 (USD MILLION)
TABLE 200. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2025-2030 (USD MILLION)
TABLE 201. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2024 (USD MILLION)
TABLE 202. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2025-2030 (USD MILLION)
TABLE 203. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 204. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2025-2030 (USD MILLION)
TABLE 213. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 214. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 217. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 218. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 219. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 220. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 221. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 222. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 223. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 224. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 225. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 228. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 229. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 230. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 231. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2024 (USD MILLION)
TABLE 232. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2025-2030 (USD MILLION)
TABLE 233. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2024 (USD MILLION)
TABLE 234. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2025-2030 (USD MILLION)
TABLE 235. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2024 (USD MILLION)
TABLE 238. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2025-2030 (USD MILLION)
TABLE 239. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2024 (USD MILLION)
TABLE 240. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2025-2030 (USD MILLION)
TABLE 241. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 242. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 243. CANADA BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 244. CANADA BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 245. CANADA BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2024 (USD MILLION)
TABLE 246. CANADA BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2025-2030 (USD MILLION)
TABLE 247. CANADA BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2018-2024 (USD MILLION)
TABLE 248. CANADA BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2025-2030 (USD MILLION)
TABLE 249. CANADA BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2024 (USD MILLION)
TABLE 250. CANADA BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2025-2030 (USD MILLION)
TABLE 251. CANADA BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 252. CANADA BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 253. CANADA BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 254. CANADA BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 255. CANADA BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 256. CANADA BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 257. CANADA BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 258. CANADA BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 259. CANADA BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 260. CANADA BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 261. CANADA BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 262. CANADA BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 263. CANADA BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. CANADA BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. CANADA BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 266. CANADA BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 267. CANADA BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 268. CANADA BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 269. CANADA BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2024 (USD MILLION)
TABLE 270. CANADA BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2025-2030 (USD MILLION)
TABLE 271. CANADA BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2024 (USD MILLION)
TABLE 272. CANADA BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2025-2030 (USD MILLION)
TABLE 273. CANADA BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 274. CANADA BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 275. CANADA BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2024 (USD MILLION)
TABLE 276. CANADA BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2025-2030 (USD MILLION)
TABLE 277. CANADA BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2024 (USD MILLION)
TABLE 278. CANADA BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2025-2030 (USD MILLION)
TABLE 279. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 280. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 281. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2024 (USD MILLION)
TABLE 282. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2025-2030 (USD MILLION)
TABLE 283. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2018-2024 (USD MILLION)
TABLE 284. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2025-2030 (USD MILLION)
TABLE 285. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2024 (USD MILLION)
TABLE 286. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2025-2030 (USD MILLION)
TABLE 287. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 288. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 289. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 290. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 291. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 292. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 293. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 294. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 295. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 296. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 297. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 298. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 299. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 302. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 303. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 304. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 305. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2024 (USD MILLION)
TABLE 306. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2025-2030 (USD MILLION)
TABLE 307. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2024 (USD MILLION)
TABLE 308. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2025-2030 (USD MILLION)
TABLE 309. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 310. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 311. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2024 (USD MILLION)
TABLE 312. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2025-2030 (USD MILLION)
TABLE 313. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2024 (USD MILLION)
TABLE 314. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2025-2030 (USD MILLION)
TABLE 315. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 316. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 317. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2024 (USD MILLION)
TABLE 318. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2025-2030 (USD MILLION)
TABLE 319. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2018-2024 (USD MILLION)
TABLE 320. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2025-2030 (USD MILLION)
TABLE 321. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2024 (USD MILLION)
TABLE 322. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2025-2030 (USD MILLION)
TABLE 323. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 324. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 325. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 326. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 327. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 328. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 329. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 330. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 331. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 332. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 333. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 334. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 335. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 336. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 337. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 338. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 339. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 340. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 341. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2024 (USD MILLION)
TABLE 342. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2025-2030 (USD MILLION)
TABLE 343. BRAZIL BIRD FLU TREATMEN

Samples

Loading
LOADING...

Companies Mentioned

  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Novartis AG
  • CSL Limited
  • Pfizer Inc.
  • Fujifilm Toyama Chemical Co., Ltd.
  • Seqirus Pty Ltd
  • Shionogi & Co., Ltd.
  • BioCryst Pharmaceuticals, Inc.

Table Information

Report AttributeDetails
No. of Pages189
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 25.86 Billion
Forecasted Market Value ( USD ) by 2030 $ 38.3 Billion
Compound Annual Growth Rate8.2%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Bird Flu Treatment - Global Strategic Business Report - Product Image

Bird Flu Treatment - Global Strategic Business Report

  • Report
  • 285 Pages
  • Global
From
H3N2 Infection - Pipeline Insight, 2025 - Product Image

H3N2 Infection - Pipeline Insight, 2025

  • Drug Pipelines
  • 80 Pages
  • Global
From
Influenza A Infections - Pipeline Insight, 2025 - Product Image

Influenza A Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • 50 Pages
  • Global
From
Common Cold Market Report and Forecast 2025-2034 - Product Image

Common Cold Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Oseltamivir Phosphate Granules Market - Global Forecast 2025-2030 - Product Image

Oseltamivir Phosphate Granules Market - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From

About the Market

The Avian Influenza Drug market is a subset of the larger Infectious Diseases Drugs market. It is composed of drugs used to treat avian influenza, a type of influenza virus that primarily affects birds, but can also infect humans. These drugs are used to reduce the severity of symptoms and prevent further spread of the virus. They are typically administered in the form of antiviral medications, such as oseltamivir and zanamivir. Vaccines are also available to help protect against avian influenza. The Avian Influenza Drug market is highly competitive, with many companies offering products to treat the virus. Some of the major players in the market include GlaxoSmithKline, Sanofi, Novartis, Merck, and Pfizer. Other companies, such as Cipla, Mylan, and Sun Pharmaceuticals, also offer products for the treatment of avian influenza. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.